Variant position: 382 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: 770 The length of the canonical sequence.
Location on the sequence:
The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: The multiple alignment of the region surrounding the variant against various orthologous sequences.
Human LKIKVCIDKDSGDVAALRGS RKFNILGTNTKVMNMEESNNG
Mouse LKIKVCIDKDSGDVAALRGS RKFNILGTNTKVMNMEESNNG
Rat LKIKVCIDKDSGDVAALRGS RKFNILGTNTKVMNMEESNNG
Pig LKIKVCIDKDSGDVAALRGS RKFNILGTNTKVMNMEESNNG
Bovine LKIKVCIDKDSGDVAALRGS RKFNILGTNTKVMNMEESNNG
Chicken LKIKVCIDKDSGDVAALRGS RKFNILGTNTKVMNMEESNNG
Sequence annotation in neighborhood: The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
Type: the type of sequence feature. Positions: endpoints of the sequence feature. Description: contains additional information about the feature.
Type Positions Description
2 – 770 Signal transducer and activator of transcription 3
STAT3 mutations in the hyper-IgE syndrome.
Holland S.M.; DeLeo F.R.; Elloumi H.Z.; Hsu A.P.; Uzel G.; Brodsky N.; Freeman A.F.; Demidowich A.; Davis J.; Turner M.L.; Anderson V.L.; Darnell D.N.; Welch P.A.; Kuhns D.B.; Frucht D.M.; Malech H.L.; Gallin J.I.; Kobayashi S.D.; Whitney A.R.; Voyich J.M.; Musser J.M.; Woellner C.; Schaffer A.A.; Puck J.M.; Grimbacher B.;
N. Engl. J. Med. 357:1608-1619(2007)
Cited for: VARIANTS AD-HIES GLN-382; LEU-382; TRP-382; LEU-384; SER-384; GLN-423; VAL-463 DEL; ASN-611; VAL-621; ILE-622; LEU-637; MET-637; GLN-644 DEL AND CYS-657;
Dominant-negative mutations in the DNA-binding domain of STAT3 cause hyper-IgE syndrome.
Minegishi Y.; Saito M.; Tsuchiya S.; Tsuge I.; Takada H.; Hara T.; Kawamura N.; Ariga T.; Pasic S.; Stojkovic O.; Metin A.; Karasuyama H.;
Cited for: VARIANTS AD-HIES GLN-382; TRP-382; ILE-389; TYR-437 AND VAL-463 DEL; CHARACTERIZATION OF VARIANTS AD-HIES GLN-382; TRP-382; ILE-389; TYR-437 AND VAL-463 DEL;
Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.